Why are Medicare and Medicaid shown separately instead of combined?

They come from two different CMS data sources with no shared claim identifier, so they can't be reconciled into one number without double-counting or guessing. Every table and chart on this page keeps them fully separate.

Why is there no private/commercial revenue figure?

Private and commercial payer data comes from Transparency in Coverage files, which only publish negotiated rates — not claims or utilization volume. Without a volume figure, no revenue number can be computed for any provider from that data.

What does "Rank" mean in the Competitive Analysis & Benchmarks tables?

For a given CPT/HCPCS code, it's this provider's position by claims volume among all providers billing that same code at that geography level (State, National, or Michigan for Medicaid) — rank 1 means the highest claims volume for that code.

Why is the Medicaid comparison limited to Michigan only?

Medicaid is administered per-state with no single national fee schedule, so a state or national comparison the way Medicare has one isn't available. Michigan (this provider's own state) is the only grouping that's conceptually meaningful.

Why are the numbers rounded to the nearest 10?

To avoid implying more precision than the underlying data supports at a single-provider level. Ratios are kept precise since they're a relative comparison, not a volume or dollar figure.

How current is this data?

The Medicare and Medicaid tables are both single current snapshots, not refreshed on a recurring schedule yet.

Adli Yakan (NPI 1417174699)

Field	Value
Entity Type	Individual
Organization	Adli Yakan
Address	18223 E 10 Mile Rd Ste 100
City	Roseville
State	MI
ZIP	48066
Taxonomy	Medical Oncology Physician
NPI Enumerated	April 19, 2007

Payer Source	Total Paid
Medicare	$1.7M
Medicaid	$0

Key Findings

This provider is effectively single‑payer: Total Medicare revenue is $1.7M and there is no Medicaid billing on file, so Medicare activity drives the entire documented public-payer footprint. Analysts should treat this profile as Medicare-centric when assessing access, utilization, and contracting exposure.

Revenue is highly concentrated: the precomputed top 3 Medicare codes by revenue account for 81.5% of total Medicare revenue, with J9271 alone generating $1.2M (70.9% of Medicare revenue). This level of concentration indicates material dependence on a single high-cost drug administration for earnings and creates sensitivity to reimbursement or utilization shifts for that therapy.

The code mix is consistent with a medical oncology practice focused on outpatient immunotherapy and chemotherapy delivery plus ongoing E/M follow-up: J9271 (pembrolizumab injection), 96413 (chemotherapy infusion), and frequent 99214 office visits appear as the top revenue drivers. Participation in the Enhancing Oncology Model is visible via M0010 claims (196 claims, $14.3K), reinforcing a structured oncology service line with monthly enhanced oncology services.

On competitive standing for the principal drug, J9271 ranks #146 of 1841 (92th percentile) and is labeled as typical/unremarkable volume, meaning the provider is an active regional deliverer of pembrolizumab but not an extreme national outlier for that drug. Despite generating the majority of this provider's Medicare revenue, the national rank suggests the J9271 activity sits within a common range for oncology infusion sites.

Office E/M volume is an outlier: 99214 shows 1.3K claims, $125K revenue (7.3% of Medicare revenue) and ranks #5433 of 479517 (99th percentile; extreme outlier). In plain terms, the provider bills established outpatient visits at a far higher rate than almost all peers nationally, implying a busy clinic with a large established-patient follow-up load.

Chemotherapy administration activity is substantively above typical: 96413 has 559 claims, $57K revenue (3.3% of Medicare revenue) and ranks #515 of 7514 (93th percentile; notably above typical national volume). Add-on and infusion codes such as 96417 (rank #302 of 3014, 90th percentile) and 96365/96375 also appear in the top codes, corroborating meaningful in-office IV therapy throughput.

The provider’s case mix includes significant hospital-based E/M work and ancillary supportive services: 99232 (843 claims, $54K; ranks #6290 of 177383, 96th percentile) and 99223 (214 claims, $30K; 95th percentile) show notable inpatient/observation activity, while phlebotomy and lab codes 36415 and 85025 (each ~1.5K claims, ~$12.3K–$12.4K) rank in the mid-to-high national percentiles. Together these items indicate an integrated practice that manages inpatient visits, infusion services, and routine diagnostic support for oncology patients.

Provider tenure is long-standing: NPI enumerated 2007-04-19 (~19 years ago), which combined with the heavy clinic and infusion volumes suggests an established oncology operation rather than a newly formed practice. This longevity plus the observed coding mix supports expectations of a mature referral base and sustained Medicare revenue concentration.

Medicare: Complete Services Breakdown

The CPT/HCPCS codes generating the most Medicare revenue for this provider.

41 rows

CPT/HCPCS Code	Description	Claims	Avg Paid	Revenue
J9271	Injection, pembrolizumab, 1 mg	28,400	$40	$1.2M
99214	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a moderate level of medical decision making, and/or the…	1,320	$100	$125K
96413	Chemotherapy is a therapeutic procedure used for the treatment of cancer via the use of chemical agents. These chemical agents (drugs) work on the cancerous cells of the body to destroy them. These…	560	$100	$57K
99232	The provider sees a patient for a subsequent hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a moderate level of medical decision making or…	840	$60	$54K
J1437	Injection, ferric derisomaltose, 10 mg	2,800	$20	$44.8K
J1439	Injection, ferric carboxymaltose, 1 mg	43,500	$1	$43.5K
99223	The provider sees a patient for an initial hospital inpatient or observation care visit involving evaluation and management (E/M). The visit involves a high level of medical decision making or the…	210	$140	$30K
99215	The provider sees an established patient for an office visit or other outpatient visit involving evaluation and management. The visit involves a high level of medical decision making, and/or the…	190	$140	$25.7K
M0010	Enhancing oncology model (eom) monthly enhanced oncology services (meos) payment for eom enhanced services	200	$70	$14.3K
J0185	Injection, aprepitant, 1 mg	13,000	$1	$13K

Showing 1–10 of 41

Medicare: Competitive Analysis & Benchmarks

How this provider's Medicare billing volume and revenue compare to other providers nationally and within its state, across 41 CPT/HCPCS codes.

View: State1 / 2

Claims Volume vs. Michigan Distribution

Adli Yakan — 11 of 25 codes billed far more than typical (above p95)

p5–p95 (all providers)p25–p75MedianThis providerOutlier

Rank Distribution — Michigan

Full comparison — all codes billed, vs. state median

41 rows

CPT/HCPCS Code	Rank	Provider Count	Median Claims	Avg Paid	Average Revenue
J9271	2	30	8,800	$40	$473.6K
J1437	2	10	2,500	$20	$39.6K
J1439	1	30	21,750	$1	$20.3K
96413	6	170	120	$100	$16.1K
J0185	1	10	10,340	$1	$12.8K
99233	2,836	4,220	70	$90	$12.3K
99232	253	6,730	90	$60	$12K
99214	55	15,470	80	$80	$11.4K
M0010	4	30	110	$70	$8.9K
99223	181	4,880	40	$130	$8.3K

Showing 1–10 of 41

Related Providers

Other providers that share a Tax Identification Number (TIN) with Adli Yakan, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Henry Ford Health St. John Hospital	IL	General Acute Care Hospital	$0	$159.7M
Cancer & Hematology Centers Of Western Mi, P.C.	MI	Specialist	$0	$59.5M
Columbus Radiology Corp	OH	Diagnostic Radiology Physician	$0	$49.9M
Henry Ford Health St. John Hospital	MI	Internal Medicine Physician	$0	$41.8M
Wilfredo Blasini	FL	Clinical Pathology Physician	$16.9M	$307.9K
Ryan Olson	FL	Anatomic Pathology & Clinical Pathology Physician	$12.8M	$80
American Oncology Partners PA	OH	Hematology & Oncology Physician	$0	$11.8M
Henry Ford Macomb Hospital Corporation	MI	Family Medicine Physician	$0	$9.2M
Robert Mcdonald	AZ	Diagnostic Radiology Physician	$7.5M	$0
David Smith	MD	Hematology & Oncology Physician	$6.4M	$0

Nearby Providers

Other providers in the same ZIP code as Adli Yakan, ranked by combined Medicare and Medicaid revenue.

Provider	State	Taxonomy	Medicare Revenue	Medicaid Revenue
Bio-med Behavioral Health Services	MI	Addiction (Substance Use Disorder) Counselor	$192.7K	$24.6M
Together Women's Health Medical Group, P.C.	MI	Obstetrics & Gynecology Physician	$0	$6.9M
Roseville Urgent Care, PC	MI	Urgent Care Clinic/Center	$0	$6.5M
City Of Roseville	MI	Ambulance	$306.8K	$2.3M
Lokesh Nagori	MI	Medical Oncology Physician	$719.1K	$0
Vera Maranci	MI	Medical Oncology Physician	$471.1K	$0
Mouhammed Joumaa	MI	Interventional Cardiology Physician	$360K	$0
Subhi Sbahi	MI	Cardiovascular Disease Physician	$336K	$0
Jimmy Haouilou	MI	Vascular Surgery Physician	$334.2K	$0
Majid Alzagoum	MI	Cardiovascular Disease Physician	$317.3K	$0

Adli Yakan — Billing Profile & Reimbursement Data

Sign up for Adli Yakan — Billing Profile & Reimbursement Data policy alerts

Adli Yakan — Billing Profile & Reimbursement Data

Sign up for Adli Yakan — Billing Profile & Reimbursement Data policy alerts

Key Findings

Medicare: Total Revenue Breakdown by CPT/HCPCS Code

Medicare: Complete Services Breakdown

Medicare: Competitive Analysis & Benchmarks

Related Providers

Nearby Providers

Frequently Asked Questions

References